To study the effectiveness of ts SeV-delivered CRISPR-Cas9 as a tool for inhibiting HIV infection in primary MDMs via targeting of CCR5, MDMs were transduced with ts SeV-Cas9-CCR5 and subsequently infected with the R5-tropic HIV strain JR-FL. Here, CCR5 is linked to HIV infectious disease.